M. Sanda

Ghost fragment ions in structure and site-specific glycoproteomics analysis

The paper identifies 'Ghost' fragment ions in glycoproteomics that can lead to false positive structure assignments and proposes a minimal intensity threshold to mitigate this issue.

LC-MS/MS-PRM Quantification of IgG glycoforms using stable isotope labeled IgG1 Fc glycopeptide standard

The paper introduces a workflow for quantifying IgG glycoforms using stable isotope labeled standards and LC-MS/MS-PRM, achieving high sensitivity and precision.

Community Evaluation of Glycoproteomics Informatics Solutions Reveals High-Performance Search Strategies of Serum N- and O-Glycopeptide Data

This study evaluates glycoproteomics software performance using human serum datasets, identifies high-performance strategies, and provides recommendations for improved analysis.

Analysis of site and structure specific core fucosylation in liver disease progression using exoglycosidase-assisted data-independent LC-MS/MS

This study quantifies core fucosylation changes in liver disease using mass spectrometry and exoglycosidase-assisted analysis of glycopeptides.

N and O glycosylation of the SARS-CoV-2 spike protein

This study identifies O- and N-glycosylation sites on the SARS-CoV-2 spike protein and their structural motifs, revealing their potential role in proteolytic activation.

PD-L1 glycosylation and its impact on binding to clinical antibodies

This study investigates PD-L1 glycosylation patterns and their impact on interactions with PD-1 and clinical antibodies, revealing site-specific glycan structures and potential functional implications.